Who evaluates public health programmes? A review of the NHS Breast Screening Programme.

作者信息

Jørgensen Karsten Juhl, Gøtzsche Peter C

机构信息

The Nordic Cochrane Centre, Rigshospitalet Dept 3343, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.

出版信息

J R Soc Med. 2010 Jan;103(1):14-20. doi: 10.1258/jrsm.2009.090342.

DOI:10.1258/jrsm.2009.090342

PMID:20056665

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2802704/

Abstract

摘要

相似文献

[1]

Who evaluates public health programmes? A review of the NHS Breast Screening Programme.

J R Soc Med. 2010-1

[2]

Mammography screening is harmful and should be abandoned.

J R Soc Med. 2015-9

[3]

Mammography screening is not as good as we hoped.

Maturitas. 2010-1

[4]

Recommending mammography screening beyond 80 years of age: a time for caution.

Womens Health (Lond). 2008-7

[5]

The NHS breast cancer screening programme.

Br J Cancer. 2003-7-7

[6]

Screening mammography.

Can J Rural Med. 2010

[7]

Early detection of breast cancer the second time around: mammography in women with a personal history of breast cancer.

Med J Aust. 2011-5-2

[8]

The overdiagnosis nightmare: a time for caution.

BMC Womens Health. 2009-12-16

[9]

Improving screening recall services for women with false-positive mammograms: a comparison of qualitative evidence with UK guidelines.

BMJ Open. 2015-1-23

[10]

[Mammography and cervical cancer screening--a systematic review about women's knowledge, attitudes and participation in Germany].

Gesundheitswesen. 2012-11

引用本文的文献

[1]

Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.

Br J Cancer. 2017-1-17

[2]

Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.

J R Soc Med. 2013-6

[3]

Women's views on overdiagnosis in breast cancer screening: a qualitative study.

BMJ. 2013-1-23

[4]

Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.

J Proteome Res. 2012-9-20

[5]

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.

Br J Cancer. 2012-4-19

[6]

The breast screening programme and misinforming the public.

J R Soc Med. 2011-9

[7]

False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial).

Cancer Epidemiol Biomarkers Prev. 2010-9-13

本文引用的文献

[1]

Screening for breast cancer with mammography.

Cochrane Database Syst Rev. 2009-10-7

[2]

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

BMJ. 2009-7-9

[3]

Fall in breast cancer deaths. A cause for celebration, and caution.

BMJ. 2009-5-27

[4]

Breast screening: the facts--or maybe not.

BMJ. 2009-1-27

[5]

Flawed inferences about screening mammography's benefit based on observational data.

J Clin Oncol. 2009-2-1

[6]

Screening and breast cancer.

N Engl J Med. 2006-2-16

[7]

Monitoring the decrease in breast cancer mortality in Europe.

Eur J Cancer Prev. 2005-12

[8]

Diagnostic performance of digital versus film mammography for breast-cancer screening.

N Engl J Med. 2005-10-27

[9]

Comparing the performance of mammography screening in the USA and the UK.

J Med Screen. 2005

[10]

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Ann Intern Med. 2002-9-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Who evaluates public health programmes? A review of the NHS Breast Screening Programme.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献